$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs 원문보기

International journal of pharmaceutics, v.514 no.1, 2016년, pp.160 - 168  

Joshi, Sameer (Aston Pharmacy School, Life and Health Sciences, Aston University) ,  Hussain, Maryam T. (Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde) ,  Roces, Carla B. (Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde) ,  Anderluzzi, Giulia (Department of Pharmaceutical and Pharmacological Sciences, University of Padova) ,  Kastner, Elisabeth (Aston Pharmacy School, Life and Health Sciences, Aston University) ,  Salmaso, Stefano (Department of Pharmaceutical and Pharmacological Sciences, University of Padova) ,  Kirby, Daniel J. (Aston Pharmacy School, Life and Health Sciences, Aston University) ,  Perrie, Yvonne (Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde)

Abstract AI-Helper 아이콘AI-Helper

Abstract Despite the substantial body of research investigating the use of liposomes, niosomes and other bilayer vesicles for drug delivery, the translation of these systems into licensed products remains limited. Indeed, recent shortages in the supply of liposomal products demonstrate the need for...

주제어

참고문헌 (38)

  1. J. Pharm. Pharmacol. Ali 62 1646 2010 10.1111/j.2042-7158.2010.01090.x Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent 

  2. Int. J. Pharm. Ali 453 225 2013 10.1016/j.ijpharm.2012.06.056 The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs 

  3. J. Pharm. Pharmacol. Azmin 37 237 1985 10.1111/j.2042-7158.1985.tb05051.x The effect of non-ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice 

  4. J. Pharm. Pharmacol. Baillie 37 863 1985 10.1111/j.2042-7158.1985.tb04990.x The preparation and properties of niosomes-non-ionic surfactant vesicles 

  5. Polymer Bally 53 5045 2012 10.1016/j.polymer.2012.08.039 Improved size-tunable preparation of polymeric nanoparticles by microfluidic nanoprecipitation 

  6. J. Mol. Biol. Bangham 8 1964 10.1016/S0022-2836(64)80115-7 Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope 

  7. Biochim. Biophys. Acta (BBA) - Biomembr. Batzri 298 1015 1973 10.1016/0005-2736(73)90408-2 Single bilayer liposomes prepared without sonication 

  8. Mol. Ther. Nucleic Acids Belliveau 1 e37 2012 10.1038/mtna.2012.28 Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA 

  9. Drug Deliv. Transl. Res. Briuglia 5 231 2015 10.1007/s13346-015-0220-8 Influence of cholesterol on liposome stability and on in vitro drug release 

  10. Dissol. Technol. Brown 30 5 2005 Apparatus 4 flow through cell: Some thoughts on operational characteristics 

  11. Capretto 27 2011 Microfluidics: Technologies and Applications Micromixing within microfluidic devices 

  12. Sci. Rep. Carugo 6 25876 2016 10.1038/srep25876 Liposome production by microfluidics: potential and limiting factors 

  13. Vaccine Conacher 19 2965 2001 10.1016/S0264-410X(00)00537-5 Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) 

  14. Adv. Drug Deliv. Rev. Cullis 3 267 1989 10.1016/0169-409X(89)90024-0 Generating and loading of liposomal systems for drug-delivery applications 

  15. Nature deMello 442 394 2006 10.1038/nature05062 Control and detection of chemical reactions in microfluidic systems 

  16. Proc. Natl. Acad. Sci. U. S. A. Felgner 84 7413 1987 10.1073/pnas.84.21.7413 Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure 

  17. Biochem. Biophys. Res. Commun. Gregoriadis 89 1287 1979 10.1016/0006-291X(79)92148-X Stability of liposomes invivo and invitro is promoted by their cholesterol content and the presence of blood cells 

  18. Biochem. J. Gregoriadis 124 58P 1971 10.1042/bj1240058P Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases 

  19. Small Hauschild 1 1177 2005 10.1002/smll.200500093 Direct preparation and loading of lipid and polymer vesicles using inkjets 

  20. J. Am. Chem. Soc. Jahn 126 2674 2004 10.1021/ja0318030 Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing 

  21. Langmuir Jahn 23 6289 2007 10.1021/la070051a Microfluidic directed formation of liposomes of controlled size 

  22. Twelfth International Conference on Miniaturized Systems for Chemistry and Life Sciences Jahn 2008 Unexpectedly high entrapment effi-ciencies in nanometer scale liposomes with hydrodynamic focusing using continuous-flow microfluidics 

  23. Chem. Eng. Sci. Jensen 56 293 2001 10.1016/S0009-2509(00)00230-X Microreaction engineering-is small better? 

  24. Int. J. Pharm. Kastner 477 361 2014 10.1016/j.ijpharm.2014.10.030 High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization 

  25. Int. J. Pharm. Kastner 485 122 2015 10.1016/j.ijpharm.2015.02.063 Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug 

  26. RSC Adv. Maeki 5 46181 2015 10.1039/C5RA04690D A strategy for synthesis of lipid nanoparticles using microfluidic devices with a mixer structure 

  27. Int. J. Pharm. Mohammed 285 23 2004 10.1016/j.ijpharm.2004.07.010 Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability 

  28. J. Micromech. Microeng. Nguyen 15 R1 2004 10.1088/0960-1317/15/2/R01 Micromixers-a review 

  29. Pharm. Res. Okada 12 576 1995 10.1023/A:1016214332030 In vitro evaluation of polymerized liposomes as an oral drug delivery system 

  30. Biophys. J. Patra 90 1121 2006 10.1529/biophysj.105.062364 Under the influence of alcohol: the effect of ethanol and methanol on lipid bilayers 

  31. Dissolut. Technol. Qureshi 13 4 18 2006 10.14227/DT130406P18 Developing discriminatory drug dissolution tests and profiles: some thoughts for consideration on the concept and its interpretation 

  32. Small Song 4 698 2008 10.1002/smll.200701029 Microfluidic synthesis of nanomaterials 

  33. Science Stroock 295 647 2002 10.1126/science.1066238 Chaotic mixer for microchannels 

  34. Adv. Colloid Interface Sci. Uchegbu 58 1 1995 10.1016/0001-8686(95)00242-I Non-ionic surfactant vesicles (niosomes): physical and pharmceutical chemistry 

  35. Lab Chip van Swaay 13 752 2013 10.1039/c2lc41121k Microfluidic methods for forming liposomes 

  36. Curr. Opin. Chem. Biol. Weibel 10 584 2006 10.1016/j.cbpa.2006.10.016 Applications of microfluidics in chemical biology 

  37. Langmuir Zhigaltsev 28 3633 2012 10.1021/la204833h Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing 

  38. Soft Matter Zook 6 1352 2010 10.1039/b923299k Effects of temperature, acyl chain length, and flow-rate ratio on liposome formation and size in a microfluidic hydrodynamic focusing device 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로